Trial
NCT00315614
Islet Cell Transplantation Alone and CD34+ Donor Bone Marrow Cell Infusion in Type 1 Diabetes Mellitus
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Miami
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Diabetes Research Institute Foundation
Condition
Type 1 Diabetes Mellitus
Intervention
Islet Transplantation and Bone Marrow
Why stopped
We did not achieve a tolerogenic profile. Subjects withdrew from protocol and enrolled in other islet transplant trials.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-04